MaxCyte Inc. (MXCT)
NASDAQ: MXCT
· Real-Time Price · USD
1.41
0.05 (3.68%)
At close: Sep 05, 2025, 3:59 PM
1.42
0.71%
After-hours: Sep 05, 2025, 05:56 PM EDT
3.68% (1D)
Bid | 1.36 |
Market Cap | 150.32M |
Revenue (ttm) | 35.75M |
Net Income (ttm) | -44.77M |
EPS (ttm) | -0.42 |
PE Ratio (ttm) | -3.36 |
Forward PE | -3.45 |
Analyst | Hold |
Ask | 1.51 |
Volume | 486,178 |
Avg. Volume (20D) | 826,995 |
Open | 1.35 |
Previous Close | 1.36 |
Day's Range | 1.35 - 1.44 |
52-Week Range | 1.26 - 5.20 |
Beta | 0.27 |
About MXCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MXCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MXCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
MaxCyte Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-29.9%
MaxCyte shares are trading lower after the company...
Unlock content with
Pro Subscription
7 months ago
+11.59%
MaxCyte shares are trading higher after the company announced expectations for a year-over-year increase in Q4 and FY24 revenue

1 month ago · fool.com
MaxCyte (MXCT) Q2 Revenue Drops 18%MaxCyte (MXCT) Q2 Revenue Drops 18%

2 months ago · businesswire.com
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in JapanTOKYO--(BUSINESS WIRE)--The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHCbi"), a subsidiary of PHC Holdings Corpor...